We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Helios Technologies
HLIO
$2.76B
| $1.06M | ﹤0.01% |
25,663
+3,350
| +15% | +$129K |
|
1827
Cooper-Standard Automotive
CPS
$558M
| $1.06M | ﹤0.01% |
17,880
+600
| +3% | +$32.9K |
|
|
NCI
1828
DELISTED
Navigant Consulting, Inc.
NCI
| $1.06M | ﹤0.01% |
81,450
-1,900
| -2% | -$27K |
|
1829
Resources Connection
RGP
$145M
| $1.05M | ﹤0.01% |
60,085
-1,100
| -2% | -$19K |
|
1830
WSFS Financial
WSFS
$4.15B
| $1.05M | ﹤0.01% |
41,640
+2,700
| +7% | +$68.9K |
|
|
LORL
1831
DELISTED
Loral Space and Communications, Inc.
LORL
| $1.05M | ﹤0.01% |
15,296
+1,900
| +14% | +$137K |
|
|
TSRO
1832
DELISTED
TESARO, Inc.
TSRO
| $1.05M | ﹤0.01% |
18,247
+2,860
| +19% | +$135K |
|
|
DEL
1833
DELISTED
Deltic Timber
DEL
| $1.04M | ﹤0.01% |
15,774
+1,500
| +11% | +$97.5K |
|
|
ADAM
1834
Adamas Trust
ADAM
$883M
| $1.04M | ﹤0.01% |
33,565
+2,825
| +9% | +$88.2K |
|
1835
Hanmi Financial
HAFC
$946M
| $1.04M | ﹤0.01% |
49,210
+1,050
| +2% | +$21.6K |
|
|
CIVI
1836
DELISTED
Civitas Resources
CIVI
| $1.04M | ﹤0.01% |
378
+65
| +21% | +$186K |
|
1837
CTS Corp
CTS
$1.89B
| $1.04M | ﹤0.01% |
57,828
+1,700
| +3% | +$28.9K |
|
|
ARRY
1838
DELISTED
Array Biopharma Inc
ARRY
| $1.04M | ﹤0.01% |
140,923
+18,825
| +15% | +$134K |
|
|
CSII
1839
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.03M | ﹤0.01% |
26,518
+3,815
| +17% | +$131K |
|
|
LOCK
1840
DELISTED
LifeLock, Inc.
LOCK
| $1.03M | ﹤0.01% |
73,313
+12,075
| +20% | +$172K |
|
1841
Flotek Industries
FTK
$1.28B
| $1.03M | ﹤0.01% |
11,623
+1,282
| +12% | +$125K |
|
1842
Washington Trust Bancorp
WASH
$741M
| $1.02M | ﹤0.01% |
26,825
+1,100
| +4% | +$41.7K |
|
|
PRFT
1843
DELISTED
Perficient Inc
PRFT
| $1.02M | ﹤0.01% |
49,482
+3,925
| +9% | +$76.1K |
|
1844
Insmed
INSM
$28.6B
| $1.02M | ﹤0.01% |
49,205
+6,975
| +17% | +$123K |
|
|
RP
1845
DELISTED
RealPage, Inc.
RP
| $1.02M | ﹤0.01% |
50,753
+9,025
| +22% | +$178K |
|
|
LL
1846
DELISTED
LL Flooring Holdings, Inc.
LL
| $1.02M | ﹤0.01% |
33,171
+3,665
| +12% | +$187K |
|
|
UN
1847
DELISTED
Unilever NV New York Registry Shares
UN
| $1.02M | ﹤0.01% |
24,419
+754
| +3% | +$31.6K |
|
1848
Brixmor Property Group
BRX
$9.32B
| $1.02M | ﹤0.01% |
38,362
+4,330
| +13% | +$113K |
|
|
GLOG
1849
DELISTED
GASLOG LTD
GLOG
| $1.01M | ﹤0.01% |
52,186
+2,300
| +5% | +$43.2K |
|
1850
8x8 Inc
EGHT
$332M
| $1.01M | ﹤0.01% |
120,534
+6,880
| +6% | +$55.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.